Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up

被引:3
作者
Kim, Sin Young [1 ]
Shin, Ji Seong [1 ]
Jang, Min Sik [1 ]
Kim, Jihye [1 ,2 ]
机构
[1] Kangdong Sacred Heart Hosp, Dept Pediat, Div Infect, Seoul, South Korea
[2] Hallym Univ, Coll Med, Chunchon, South Korea
关键词
epidemiology; allergy and Immunology; infectious disease medicine; cardiology; EPIDEMIOLOGIC FEATURES; SOUTH-KOREA; JAPAN; CORTICOSTEROIDS; MANAGEMENT; TAIWAN;
D O I
10.1136/archdischild-2022-324467
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
ObjectiveTo identify the clinical characteristics of patients with recurrent Kawasaki disease (KD). DesignA nationwide, population-based, cohort study using the Korean National Health Insurance claims database between 2013 and 2016. PatientsA total of 19 456 patients under the age of 5 years who were diagnosed with initial episode of KD were included. A minimum follow-up period of 3 years was mandatory for inclusion. Main outcome measuresThe epidemiological and clinical profiles were compared between KD patients with and without recurrence. ResultsThe overall recurrence rate of KD was 3.84% (n=748), and the median interval to recurrence was 498 days (IQR: 257-860 days). Approximately 70% of all recurrences occurred within 2 years of the initial diagnosis. The annual proportions of recurrence were 40%, 28%, 18%, 8% and 4% from the first to the fifth year following the initial episode, respectively. Recurrence rates were significantly higher in patients aged <1 year than in those aged 4-5 years (4.65% vs 2.22%) and those who showed resistance to an initial dose of intravenous immunoglobulin (IVIG) (10.00% vs 3.18%). Allergic comorbidities and coronary artery complications at the initial episode were not associated with increased rates of recurrence. ConclusionsWe clearly identified the annual recurrence rates and their intervals from the initial episode according to the various factors identified, including young age and resistance to initial IVIG. Our results, based on a nationwide cohort, can be used as reference for follow-up management in patients with KD and in future studies.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 32 条
[21]   Descriptive Epidemiology of Kawasaki Disease in Japan, 2011-2012: From the Results of the 22nd Nationwide Survey [J].
Makino, Nobuko ;
Nakamura, Yosikazu ;
Yashiro, Mayumi ;
Ae, Ryusuke ;
Tsuboi, Satoshi ;
Aoyama, Yasuko ;
Kojo, Takao ;
Uehara, Ritei ;
Kotani, Kazuhiko ;
Yanagawa, Hiroshi .
JOURNAL OF EPIDEMIOLOGY, 2015, 25 (03) :239-245
[22]   Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association [J].
McCrindle, Brian W. ;
Rowley, Anne H. ;
Newburger, Jane W. ;
Burns, Jane C. ;
Bolger, Anne F. ;
Gewitz, Michael ;
Baker, Annette L. ;
Jackson, Mary Anne ;
Takahashi, Masato ;
Shah, Pinak B. ;
Kobayashi, Tohru ;
Wu, Mei-Hwan ;
Saji, Tsutomu T. ;
Pahl, Elfriede .
CIRCULATION, 2017, 135 (17) :E927-E999
[23]   Cardiac sequelae in recurrent cases of Kawasaki disease: A comparison between the initial episode of the disease and a recurrence in the same patients [J].
Nakamura, Y ;
Oki, I ;
Tanihara, S ;
Ojima, T ;
Yanagawa, H .
PEDIATRICS, 1998, 102 (06)
[24]  
Nakamura Y, 1996, EUR J PEDIATR, V155, P303
[25]   INCIDENCE RATE OF RECURRENT KAWASAKI-DISEASE IN JAPAN [J].
NAKAMURA, Y ;
HIROSE, K ;
YANAGAWA, H ;
KATO, H ;
KAWASAKI, T .
ACTA PAEDIATRICA, 1994, 83 (10) :1061-1064
[26]   Increasing incidence of Kawasaki disease in Japan: Nationwide survey [J].
Nakamura, Yosikazu ;
Yashiro, Mayumi ;
Uehara, Ritei ;
Oki, Izumi ;
Kayaba, Kazunori ;
Yanagawa, Hiroshi .
PEDIATRICS INTERNATIONAL, 2008, 50 (03) :287-290
[27]   Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease [J].
Quasney, MW ;
Bronstein, DE ;
Cantor, RM ;
Zhang, Q ;
Stroupe, C ;
Shike, H ;
Bastian, JF ;
Matsubara, T ;
Fujiwara, M ;
Akimoto, K ;
Newburger, JW ;
Burns, JC .
PEDIATRIC RESEARCH, 2001, 49 (05) :686-690
[28]   Corticosteroids in the treatment of the acute phase of Kawasaki disease [J].
Shinohara, M ;
Sone, K ;
Tomomasa, T ;
Morikawa, A .
JOURNAL OF PEDIATRICS, 1999, 135 (04) :465-469
[29]   Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan [J].
Sudo, Daisuke ;
Makino, Nobuko ;
Nakamura, Yosikazu .
ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (09) :848-852
[30]   Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30years [J].
Sudo, Daisuke ;
Nakamura, Yosikazu .
ACTA PAEDIATRICA, 2017, 106 (05) :796-800